Postgraduate Diploma of London School of Hygiene and Tropical Medicine
MSc. – London School of Economics and Political Science
MSc. (Distinction) – Glasgow Caledonian University
PhD – University of South Wales
Dr. Touray has extensive professional and academic background in both development work and the health sectors. In 1992 he joined Action Aid (The Gambia) a UK charity operating in many developing countries working with the poor and the needy to help them fight hunger and poverty. He worked for the organisation in various capacities and at grassroots levels. With the United Nations Development Programme Dr. Touray served as National Expert/Project Coordinator to set-up the National Planning Commission for the Government of the Gambia. During this period he designed and coordinated a number of research activities including the Poverty and Social Impact Analysis study the objective of which was to evaluate access to basic education and healthcare and its impact on household income poverty in The Gambia.
In the areas of health he was a member of the randomised double blind placebo-controlled Pneumococcal Polysaccharide Conjugate Vaccine Trial (PVT) team with the Medical Research Council (UK) Laboratories where in addition to his clinical trial coordination functions he designed and implemented the economic evaluation component of the study. Dr. Touray served in many committees including the Ministry of Health-MRC/PVT Working Group Committee, the PVT’s Local and International Steering Committees and the special committee set up to design the Pneumococcal Surveillance programme in The Gambia which is currently ongoing.
Dr. Touray was a full time member of staff of the University of South Wales in the Health Economics and Policy Research Unit (HEPRU) serving as Research Fellow (Health Economics) before joining Swansea Centre for Health Economics (SCHE), Swansea University as Research Fellow following the transfer of HEPRU to SCHE. He is now serving as a Research Fellow for Surrey Health Economics Centre, University of Surrey.
Dr. Touray has many professional and academic qualifications including an MSc in Development Management (with distinction) from Glasgow Caledonian University and an MSc in Health Policy, Planning and Finance specialising in Economics of Health and Healthcare, and Health Systems and Policies from London School of Economics and Political Science. His PhD from University of South Wales looked into the understanding of behaviours and its influence on demand for overweight/obesity preventive goods by the UK’s adult population, and how such behaviours can be manipulated to increase demand for the preventive goods.
His specific interest is in obesity and related researches. He also has interest in economic evaluations along clinical trials; health policy, planning and financing; the understanding of behavioural elements on healthcare decisions and its economic impact.
1. I was a member of the trial of 9-valent Pneumococcal Conjugate Vaccine management team (Lancet: vol. 365, March 26, 2005).
2. Touray, M.M.L, Hutubessy, R. and Acharya, A. (2011), The cost effectiveness of pneumococcal conjugate vaccine in the routine infant immunisation programme of The Gambia. Journal of Pharmaceutical Health Services Research, Vol 2(3): 175-184. doi: 10.1111/j.1759-8893.2011.00057.x
3. Touray, M.M.L. (2013), Research on obesity – time to think about the next agendas. Progress in Health Sciences, Vol 3 (2)
4. Touray, M.M.L. (2014). Development of a Theory Based Dynamic Model on Demand for Obesity Preventive Goods. Journal of Behavioural Economics, Finance, Entrepreneurship, Accounting and Transport, Vol2(3), 70-76.
5. Touray, M. M.L. (2018), Estimation of Quality-adjusted Life Years alongside clinical trials: the impact of ‘time-effects’ on trial results. J Pharm Health Serv Res. doi:10.1111/jphs.12218
6. Antonini, A., Gentile, G., Giglio, M., Marcante, A., Gage, H., Touray, M.M.L., Fotiadis, D.I., Gatsios, D., Konitsiotis, S., Timotijevic, L., Egan, B., Hodgkins, H., Biundo, R., Pellicano, C. and on behalf of the PD_Manager consortium. (2018). Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson’s disease (PD_Manager): study protocol for a pilot randomised controlled trial. Trials 19:492
7. Raats, M, Bartos, S, Timotijevic, L, Peacock, M, Hodgkins, C, Touray, M, Geelen, A, Maringer, M, Normann, A, Verain, MCD, Zimmermann, KL (ed.), van ’t Veer, P (ed.) & Engberg Mikkelson, B (ed.) 2018, Paper on quality criteria and overview of criteria applied to available data/methods – WP6: deliverable D6.4. EU.
8. Gregory, J.W., Townson, J., Channon, S., Cohen, D., Longo, M., Davies, J.H., Harman, N., Hood, K., Pickles, T, Playle, R., Randell, T., Robling, M., Touray, M., Trevelyan, N., Warner, J.T., Lowes, L. Effectiveness of home or hospital initiation of treatment at diagnosis for children with type 1 diabetes (DECIDE trial): a multicentre individually randomised controlled trial. Manuscript ID bmjopen-2019-032317 being prepared for publication.
9. Waight, M., Elawady, A., Gage, H., Touray, M., & Adhya, S. (2019). Day case complex devices: the state of the UK. Open heart, 6(1), e001023.
10. Macken, L., Mason, L., Bremner, S., Gage, H., Touray, M., Evans, C., … & Crook, D. (2019, April). Long term palliative abdominal drains versus large volume paracentesis in refractory ascites due to cirrhosis: a multi-centre feasibility randomised controlled trial (the REDUCe Study). Journal of Hepatology (Vol. 70, pp. E660-E661).
11. mhealth for remote monitoring and management of Parkinson’s disease: determinants of compliance and validation of a tremor evaluation method (Preprint). September 2019 DOI: 10.2196/preprints.16414
Dixon MA, Touray MML, Prada JM, Gage H, Jackson D, Taylor E, Gavidia C, Basáñez MG, Villavicencio J, Flores U, Calcina J, Larrieu E, Vigilato MAN, Del Rio Vilas V(2019). A modelling and economic framework to support Cystic echinococcosis control in Peru. International Society for Economics and Social Sciences of Animal Health (ISESSAH) conference 20th & 21st July 2019 in Atlanta, USA.
Macken L, Mason L, Gage H, Touray M, Williams P, Bremner S, Evans C, Cooper M, Timeyin J, Steer S, Lambert D, Crook D, Austin M, Parnell N, Thomson S, Sheridan D, Wright M, Isaacs P, Hashim A, Verma S. (2019). Clinical, patient reported and health economic outcomes from the REDUCe Study: Palliative Long term abdominal drains versus large volume paracentesis in refractory ascites due to End Stage Liver Disease. EASL International Liver Congress, Vienna, Austria, 10/04/2019-14/04/2019
The Association for the Study of Obesity – UK (ASO)
The International Association for the Study of Obesity (IASO)
Welsh Health Economist Study Group (WHEG)
The Health Economics Study Group (HESG)
If you are a journalist on deadline and you need to speak with a member of university staff with particular expertise, please contact the Press Office.